潛能恆信(300191.SZ):周子龍7月22日以來共減持1.5%股份
格隆匯12月1日丨潛能恆信(300191.SZ)公佈,公司2021年12月1日收到控股股東一致行動人周子龍吿知函,為支持公司控股股東周錦明籌措資金不低於2.5億元(資金用途:(1)鎖定國裕平台至少1年租約並負責平台維護與保養,以確保COSL可繼續使用國裕平台完成鑽井總包服務(2)全資購買一座與國裕平台同等作業能力的自升式鑽井平台為智慧石油提供海上鑽井作業服務保障及公司戰略目標實現),周子龍於2021年7月22日-11月30日,通過大宗交易方式合計減持股份480萬股,佔公司總股本的1.50%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.